Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions

被引:41
|
作者
Khorram, O [1 ]
Garthwaite, M [1 ]
Grosen, E [1 ]
Golos, T [1 ]
机构
[1] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA
关键词
growth hormone-releasing hormone; endometrium; ovary; endometriosis; endometrial cancer; ovarian cancer;
D O I
10.1016/S0015-0282(00)01658-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine uterine and ovarian expression of growth hormone-releasing hormone (GHRH) messenger RNA (mRNA) in benign and pathologic gynecologic states. Design: Case-control study. Setting: Tertiary-care academic department. Patient(s): Women undergoing hysterectomy for benign or malignant gynecologic conditions. Intervention(s): Ovarian and uterine tissue was obtained for measurement of GHRH mRNA levels by reverse transcription polymerase chain reaction. Main Outcome Measure(s): Levels of GHRH mRNA in normal tissues were compared with those in tissues with pathologic abnormalities. Result(s): Growth hormone-releasing hormone mRNA was detectable in the ovary, endometrium, myometrium, fallopian tubes, and placenta. Levels of GHRH mRNA were significantly increased in secretory endometrium compared with proliferative endometrium. Hormone replacement therapy did not affect endometrial GHRH mRNA levels. Uterine myomas expressed similar levels of GHRH mRNA as normal myometrium. No changes in endometrial GHRH mRNA were detected in endometrial cancers compared with normal endometrium or myometrium obtained from the same patient; however, these levels were higher than those in noncancerous myometrial tissue obtained from other patients with benign gynecologic disease. In ovarian tissue, no differences in GHRH mRNA were found between premenopausal and postmenopausal women. Ovarian GHRH mRNA was significantly decreased in endometriotic cysts, whereas significantly greater GHRH expression occurred in ovarian cancer compared with normal ovarian tissue. Conclusion(s): Endometrial and ovarian GHRH gene transcription are altered in selective physiologic and pathologic states and are influenced by such factors as ovarian hormones, Because it is a growth factor, GHRH may promote endometrial proliferation and may be involved in the pathogenesis of ovarian and endometrial cancer and endometriosis. (C) 2001 by American Society for Reproductive Medicine.
引用
收藏
页码:174 / 179
页数:6
相关论文
共 50 条
  • [31] Pituitary growth hormone-releasing factor receptor expression in normal and dwarf rats
    Carmignac, DF
    Flavell, DM
    Robinson, ICAF
    NEUROENDOCRINOLOGY, 1996, 64 (03) : 177 - 185
  • [32] LONG-TERM EFFECTS OF HUMAN GROWTH HORMONE-RELEASING HORMONE AND PHOTOPERIOD ON HORMONE-RELEASE AND PUBERTY IN DAIRY HEIFERS
    RINGUET, H
    PELLETIER, G
    BRAZEAU, P
    GAUDREAU, P
    GUILBAULT, LA
    MORISSET, J
    COUTURE, Y
    PETITCLERC, D
    JOURNAL OF ANIMAL SCIENCE, 1994, 72 (10) : 2709 - 2717
  • [33] Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide
    Chatzistamou, I
    Schally, AV
    Varga, JL
    Groot, K
    Armatis, P
    Bajo, AM
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (11) : 645 - 652
  • [34] Myogenic expression of an injectable protease-resistant growth hormone-releasing hormone augments long-term growth in pigs
    Draghia-Akli, R
    Fiorotto, ML
    Hill, LA
    Malone, PB
    Deaver, DR
    Schwartz, RJ
    NATURE BIOTECHNOLOGY, 1999, 17 (12) : 1179 - 1183
  • [35] Growth hormone-releasing hormone (GHRH)-GH-somatic growth and luteinizing hormone (LH)RH-LH-ovarian axes in adult female transgenic mice expressing human GH gene
    Sasaki, F
    Tojo, H
    Iwama, Y
    Miki, N
    Maeda, K
    Ono, M
    Kiso, Y
    Okada, T
    Matsumoto, Y
    Tachi, C
    JOURNAL OF NEUROENDOCRINOLOGY, 1997, 9 (08) : 615 - 626
  • [36] Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells
    Günthert, AR
    Gründker, C
    Hollmann, K
    Emons, G
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 294 (01) : 11 - 15
  • [37] GROWTH HORMONE-RELEASING HORMONE AND SOMATOSTATIN INFLUENCE NEURONAL EXPRESSION IN DEVELOPING CHICK BRAIN .3. GABAERGIC NEURONS
    KENTROTI, S
    VERNADAKIS, A
    BRAIN RESEARCH, 1991, 562 (01) : 34 - 38
  • [38] GROWTH HORMONE-RELEASING HORMONE AND SOMATOSTATIN INFLUENCE NEURONAL EXPRESSION IN DEVELOPING CHICK BRAIN .2. CHOLINERGIC NEURONS
    KENTROTI, S
    VERNADAKIS, A
    BRAIN RESEARCH, 1990, 512 (02) : 297 - 303
  • [39] Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice
    Miyazaki, M
    Schally, AV
    Nagy, A
    Lamharzi, N
    Halmos, G
    Szepeshazi, K
    Armatis, P
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (05) : 1095 - 1103
  • [40] Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression
    Wu, Hsien-Ming
    Huang, Hong-Yuan
    Schally, Andrew V.
    Chao, Angel
    Chou, Hung-Hsueh
    Leung, Peter C. K.
    Wang, Hsin-Shih
    ONCOTARGET, 2017, 8 (03) : 4410 - 4421